Adherence to CheckMate 577 Within a Community Health Care System in the First 2 Years After Approval
In the first 2 years after CheckMate 577, results within our health care system suggest high clinician adherence to and patient acceptance of adjuvant immunotherapy with decreased adoption in more socioeconomically challenged oncology offices. In addition, compliance with the year-long adjuvant regimen mirrored clinical trial results. These results warrant further validation in a more diverse, less affluent population.
Authors
- Brian E. Louie (ORCID: https://orcid.org/0000-0002-7599-1000)
- Adam J. Bograd (ORCID: https://orcid.org/0000-0002-5855-7245)
- Peter White (ORCID: https://orcid.org/0000-0003-2933-8323)
- Eric Vallières (ORCID: https://orcid.org/0000-0003-1732-2658)
- Alexander S. Farivar (ORCID: https://orcid.org/0000-0002-4224-958X)
- John M. Campbell (ORCID: https://orcid.org/0009-0003-8770-7788)
Publication Details
- Journal
- Annals of Thoracic Surgery Short Reports
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.atssr.2025.01.021
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00